Conservative group FreedomWorks urges Republicans to vote 'no' on health-care bill

Just a day ahead of the House's scheduled vote on the GOP health-care bill, conservative advocacy group FreedomWorks announced its opposition to Republicans' ObamaCare replacement plan. In a letter, FreedomWorks urged Republican lawmakers to vote 'no' on the American Health Care Act, arguing it "does not go far enough to permanently dismantle the ObamaCare framework."
"There are parts of the American Health Care Act that bring about positive reforms, including the expansion of health savings accounts (HSAs), the repeal of most of ObamaCare's taxes, and Medicaid reforms," the letter said. "Unfortunately, even with recently submitted changes, the American Health Care Act has too many ObamaCare-like flaws." The letter warned Republicans that Americans will judge the bill based solely on whether health-insurance premiums decline; if premiums don't go down because the AHCA "leaves in place parts of ObamaCare that have caused premiums to rise, Republicans will pay a price."
FreedomWorks is just the latest conservative group to come out against the GOP health-care bill. Earlier this week, both Heritage Action and Club for Growth warned Republican lawmakers the AHCA does not go far enough to undo ObamaCare.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
At least 25 members of the House Freedom Caucus plan to oppose the bill, raising the question of whether the Republican Party can eke out enough votes to get the bill passed.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
Help! Do we really need four Beatles biopics?
Talking Point The cast of Sam Mendes' Beatles biopics has been announced
By Chas Newkey-Burden, The Week UK Published
-
Test driving the Rolls-Royce Spectre Black Badge
The Week Recommends We take the most powerful Rolls-Royce ever built for a spin in Barcelona
By Fergus Scholes Published
-
Tuberculosis is seeing a resurgence, and it's only going to get worse
Under the radar The spread of the deadly infection is buoyed by global unrest
By Devika Rao, The Week US Published
-
Measles outbreak spreads, as does RFK Jr.'s influence
Speed Read The outbreak centered in Texas has grown to at least three states and Health Secretary Robert F. Kennedy Jr. is promoting unproven treatments
By Peter Weber, The Week US Published
-
RFK Jr. offers alternative remedies as measles spreads
Speed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows
By Peter Weber, The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published